MCGINLEY KATHLEEN 4

Accession 0001181431-12-036823

CIK 0000930553other

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:03 PM ET

Size

36.3 KB

Accession

0001181431-12-036823

Insider Transaction Report

Form 4

Period: 2012-06-06

ISTA PHARMACEUTICALS INCISTA

MCGINLEY KATHLEEN

VP, HR & Corp. Facilities

Transactions

Disposition to Issuer
Option (right to buy)
2012-06-06−20,000→ 0 total
Exercise: $9.41Exp: 2013-08-06→ Common Stock (20,000 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−65,000→ 0 total
Exercise: $6.92Exp: 2014-02-05→ Common Stock (65,000 underlying)
Disposition to Issuer
Common Stock
2012-06-06$9.10/sh−97,508$887,323→ 0 total
Disposition to Issuer
Option (right to buy)
2012-06-06−9,981→ 0 total
Exercise: $6.82Exp: 2021-02-07→ Common Stock (9,981 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−7,916→ 0 total
Exercise: $3.63Exp: 2020-02-02→ Common Stock (7,916 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−18,604→ 0 total
Exercise: $4.46Exp: 2018-02-08→ Common Stock (18,604 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−15,662→ 0 total
Exercise: $7.43Exp: 2017-02-02→ Common Stock (15,662 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−7,126→ 0 total
Exercise: $1.04Exp: 2019-02-03→ Common Stock (7,126 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−17,412→ 0 total
Exercise: $1.04Exp: 2019-02-03→ Common Stock (17,412 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−17,467→ 0 total
Exercise: $6.77Exp: 2016-02-16→ Common Stock (17,467 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−21,310→ 0 total
Exercise: $10.27Exp: 2015-02-17→ Common Stock (21,310 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−690→ 0 total
Exercise: $10.27Exp: 2015-02-17→ Common Stock (690 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−100,000→ 0 total
Exercise: $3.75Exp: 2021-11-30→ Common Stock (100,000 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−24,675→ 0 total
Exercise: $6.82Exp: 2021-02-07→ Common Stock (24,675 underlying)
Disposition to Issuer
Option (right to buy)
2012-06-06−16,626→ 0 total
Exercise: $3.63Exp: 2020-02-02→ Common Stock (16,626 underlying)

Footnotes (15)

[F1]Disposed of pursuant to agreement and plan of merger by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger.
[F10]The option which was fully vested on 2/02/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $1.67 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F11]The option which was fully vested on 12/16/09 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.33 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F12]The option which was fully vested on 12/17/08 was cancelled in the Merger Agreement.
[F13]The option which was fully vested on 02/17/09 was cancelled in the Merger Agreement.
[F14]The option which was fully vested on 02/05/08 was cancelled in the Merger Agreement.
[F15]The option was fully vested on 8/6/2007 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.18 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F2]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.35 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F3]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F4]The option of which 1,623 shares were unvested and 8,358 shares were vested was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F5]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F6]The option was fully vested on 2/2/2011 was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F7]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.06 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F8]The option was fully vested on 2/3/2012 was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.06 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
[F9]The option was fully vested on 2/3/2012 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.64 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).

Documents

1 file

4
rrd348833.xmlPrimary
FORM 4

Issuer

ISTA PHARMACEUTICALS INC

CIK 0000930553

→

Entity typeother

Related Parties

filerCIK 0001280509

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 5:03 PM ET
Size: 36.3 KB

View on SEC.gov